Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvedBy |
gptkb:FDA
1962 |
| gptkbp:ATCCode |
M03BX09
|
| gptkbp:chemicalClass |
gptkb:oxazolidinone
|
| gptkbp:contraindication |
gptkb:anemia
severe renal impairment severe hepatic impairment |
| gptkbp:countryOfOperation |
gptkb:United_States
|
| gptkbp:form |
gptkb:tablet
|
| gptkbp:genericName |
gptkb:metaxalone
|
| https://www.w3.org/2000/01/rdf-schema#label |
Skelaxin
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:King_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
central muscle relaxant
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:prescriptionStatus |
Rx-only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
dizziness headache drowsiness |
| gptkbp:usedFor |
muscle pain
musculoskeletal conditions |
| gptkbp:bfsParent |
gptkb:King_Pharmaceuticals
|
| gptkbp:bfsLayer |
5
|